COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

Phase 1

Completed

Conditions: Diabetes
Type 1 Diabetes

Interventions: Drug: Alpha 1-Antitrypsin (AAT, Aralast NP)

First Posted Date: 2011-03-21

Last Posted Date: 2017-03-24

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 12

Registration Number: NCT01319331

Locations: 🇺🇸
Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, United States

Population Versus Practice-based Interventions to Increase Immunizations

Not Applicable

Completed

Conditions: Health Services Research
Comparative Effectiveness
Immunization

Interventions: Behavioral: Recall conducted centrally by local health department
Behavioral: Recall conducted by private practices

First Posted Date: 2011-02-16

Last Posted Date: 2013-06-21

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 31567

Registration Number: NCT01296906

Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents

Phase 1

Completed

Conditions: Immunosenescence
Shingles

Interventions: Biological: Varicella Zoster Virus Vaccine (Zostavax)

First Posted Date: 2010-12-17

Last Posted Date: 2021-06-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 33

Registration Number: NCT01262300

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Exercise for People With Parkinson's Disease

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Behavioral: Flexibility and Function exercise program
Behavioral: Home exercise program
Behavioral: Aerobic Exercise

First Posted Date: 2010-12-10

Last Posted Date: 2012-10-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 163

Registration Number: NCT01257945

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer

Phase 1

Completed

Conditions: Recurrent Head and Neck Cancer

Interventions: Drug: IPI-926 and Cetuximab

First Posted Date: 2010-12-07

Last Posted Date: 2014-01-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 9

Registration Number: NCT01255800

Locations: 🇺🇸
University of Colorado Denver, Denver, Colorado, United States

Medication Management and Culture of Safety

Not Applicable

Completed

Conditions: Cardiovascular Disease

Interventions: Behavioral: EHR prompt and patient prompt
Behavioral: academic detailing
Behavioral: Electronic Health Record (EHR) prompt

First Posted Date: 2010-11-24

Last Posted Date: 2019-04-17

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 7000

Registration Number: NCT01247454

Locations: 🇺🇸
University Hospital Clinics, Denver, Colorado, United States

Muscle Treatment for Management of Pain & Disability in Tension-type Headache

Phase 2

Completed

Conditions: Tension-type Headache

Interventions: Other: massage
Other: ultrasound

First Posted Date: 2010-11-19

Last Posted Date: 2015-12-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 69

Registration Number: NCT01244555

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

Clinical Pharmacology of Aliskiren in Combination With Cyclosporine in Cardiac Transplantation

Phase 4

Terminated

Conditions: Hypertension
Cardiac Transplantation

Interventions: Drug: Aliskiren

First Posted Date: 2010-11-07

Last Posted Date: 2018-06-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1

Registration Number: NCT01235910

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Safety of Heparin in Patients With Septic Shock

Phase 2

Withdrawn

Conditions: Sepsis

Interventions: Drug: heparin

First Posted Date: 2010-11-04

Last Posted Date: 2014-05-20

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01234285

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Uric Acid and the Endothelium in CKD

Not Applicable

Completed

Conditions: Kidney Disease

Interventions: Other: Placebo
Drug: Allopurinol

First Posted Date: 2010-10-27

Last Posted Date: 2017-06-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 80

Registration Number: NCT01228903

Locations: 🇺🇸
University of Colorado at Denver, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy